These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 23984927

  • 1. Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation.
    Myat A, Ahmad Y, Haldar S, Tantry US, Redwood SR, Gurbel PA, Lip GY.
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1029-49. PubMed ID: 23984927
    [Abstract] [Full Text] [Related]

  • 2. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY, Laroche C, Popescu MI, Rasmussen LH, Vitali-Serdoz L, Dan GA, Kalarus Z, Crijns HJ, Oliveira MM, Tavazzi L, Maggioni AP, Boriani G.
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [Abstract] [Full Text] [Related]

  • 3. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H, Walter M, Walter C, Vetter S.
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [Abstract] [Full Text] [Related]

  • 4. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP.
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [Abstract] [Full Text] [Related]

  • 5. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [Abstract] [Full Text] [Related]

  • 6. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M, CCS Atrial Fibrillation Guidelines Committee.
    Can J Cardiol; 2011 Jul; 27(1):74-90. PubMed ID: 21329865
    [Abstract] [Full Text] [Related]

  • 7. Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation).
    Patti G, Lucerna M, Pecen L, Siller-Matula JM, Cavallari I, Kirchhof P, De Caterina R.
    J Am Heart Assoc; 2017 Jul 23; 6(7):. PubMed ID: 28736385
    [Abstract] [Full Text] [Related]

  • 8. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
    Cairns JA, McMurtry MS.
    Can J Cardiol; 2013 Jul 23; 29(7 Suppl):S60-70. PubMed ID: 23790600
    [Abstract] [Full Text] [Related]

  • 9. Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.
    Overvad TF, Larsen TB, Albertsen IE, Rasmussen LH, Lip GY.
    Expert Rev Cardiovasc Ther; 2013 Dec 23; 11(12):1619-29. PubMed ID: 24215192
    [Abstract] [Full Text] [Related]

  • 10. What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?
    Lip GY.
    J R Coll Physicians Edinb; 2012 Dec 23; 42 Suppl 18():35-44. PubMed ID: 22518392
    [Abstract] [Full Text] [Related]

  • 11. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.
    Adv Ther; 2012 Jun 23; 29(6):491-507. PubMed ID: 22684583
    [Abstract] [Full Text] [Related]

  • 12. Atrial fibrillation: stroke prevention in older adults.
    Quinn GR, Fang MC.
    Clin Geriatr Med; 2012 Nov 23; 28(4):617-34. PubMed ID: 23101573
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Can we predict stroke in atrial fibrillation?
    Lip GY.
    Clin Cardiol; 2012 Jan 23; 35 Suppl 1(Suppl 1):21-7. PubMed ID: 22246948
    [Abstract] [Full Text] [Related]

  • 15. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S, Trappolini M, Chillotti FM.
    Minerva Cardioangiol; 2001 Feb 23; 49(1):1-13. PubMed ID: 11279381
    [Abstract] [Full Text] [Related]

  • 16. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R, Olsson SB, Lip GY, Camm AJ, Breithardt G, Capucci A, Meeder JG, Prins MH, Lévy S, Crijns HJ, Euro Heart Survey Investigators.
    Am Heart J; 2007 Jun 23; 153(6):1006-12. PubMed ID: 17540203
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
    Becattini C, Vedovati MC, Agnelli G.
    Thromb Res; 2012 Mar 23; 129(3):392-400. PubMed ID: 22264937
    [Abstract] [Full Text] [Related]

  • 19. Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.
    Guo Y, Lip GY, Apostolakis S.
    Hosp Pract (1995); 2013 Feb 23; 41(1):71-8. PubMed ID: 23466969
    [Abstract] [Full Text] [Related]

  • 20. Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
    Escobar C, Barrios V, Jimenez D.
    Cardiovasc Ther; 2010 Oct 23; 28(5):295-301. PubMed ID: 20718760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.